Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 28Terminated 13Recruiting 7Active not recruiting 6Withdrawn 1Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 7Leukemia 4Multiple Myeloma 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hodgkin Disease 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Biphenotypic, Acute 1Hematologic Diseases 1Hemangiosarcoma 1Castrate-resistant Metastatic Prostate Cancer 1Blast Crisis 1

Interventions

Cyclophosphamide 8Azacitidine 8fludarabine phosphate 6fludarabine 6Peripheral Blood Stem Cell Transplantation 6Whole-Body Irradiation 5Methotrexate 5Cyclosporine 5Busulfan 5Decitabine 4Tacrolimus 3Mycophenolic Acid 3Filgrastim 3Cytarabine 3AP 1903 reagent 3venetoclax 2magrolimab 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Saline Solution 2Radiotherapy 2Nivolumab 2Cyclosporins 2Biopsy 2Alemtuzumab 2tumor-cells apoptosis factor, human 1sabatolimab 1ponatinib 1plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Myelodysplastic Syndromes × Granulocyte Colony-Stimulating Factor × Clear all
NCT05170828 2026-02-24

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Ossium Health, Inc.

Phase 1 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡